Depreciation Amortization - Skye Bioscience Inc (NASDAQ:SKYE) - Alpha Spread

Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.49 USD 4.77% Market Closed
Market Cap: 154.1m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Skye Bioscience Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Depreciation & Amortization
$111.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
27%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.5B
CAGR 3-Years
-1%
CAGR 5-Years
35%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
$2.8B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.1B
CAGR 3-Years
14%
CAGR 5-Years
21%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$208.6m
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$453.2m
CAGR 3-Years
20%
CAGR 5-Years
20%
CAGR 10-Years
26%

See Also

What is Skye Bioscience Inc's Depreciation & Amortization?
Depreciation & Amortization
111.6k USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Depreciation & Amortization amounts to 111.6k USD.

What is Skye Bioscience Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
27%

Over the last year, the Depreciation & Amortization growth was -20%.

Back to Top